Biomarker clustering in autosomal dominant Alzheimer's disease

被引：6

作者：

Luckett, Patrick H. ^{[1
]}

Chen, Charlie ^{[1
]}

Gordon, Brian A. ^{[1
]}

Wisch, Julie ^{[1
]}

Berman, Sarah B. ^{[2
]}

Chhatwal, Jasmeer P. ^{[3
]}

Cruchaga, Carlos ^{[1
]}

Fagan, Anne M. ^{[1
]}

Farlow, Martin R. ^{[4
]}

Fox, Nick C. ^{[5
]}

Jucker, Mathias ^{[6
,7
]}

Levin, Johannes ^{[8
,9
,10
]}

Masters, Colin L. ^{[11
]}

Mori, Hiroshi ^{[12
]}

Noble, James M. ^{[13
,14
]}

Salloway, Stephen ^{[15
,16
]}

Schofield, Peter R. ^{[17
,18
]}

Brickman, Adam M. ^{[19
,20
]}

Brooks, William S. ^{[17
,18
]}

Cash, David M. ^{[5
]}

Fulham, Michael J. ^{[19
,20
]}

Ghetti, Bernardino ^{[4
]}

Jack, Clifford R., Jr. ^{[21
]}

Voeglein, Jonathan ^{[22
,23
]}

Klunk, William E. ^{[2
]}

Koeppe, Robert ^{[24
]}

Su, Yi ^{[25
]}

Weiner, Michael ^{[26
,27
]}

Wang, Qing ^{[1
]}

Marcus, Daniel ^{[1
]}

Koudelis, Deborah ^{[1
]}

Joseph-Mathurin, Nelly ^{[1
]}

Cash, Lisa ^{[1
]}

Hornbeck, Russ ^{[1
]}

Xiong, Chengjie ^{[1
]}

Perrin, Richard J. ^{[1
]}

Karch, Celeste M. ^{[1
]}

Hassenstab, Jason ^{[1
]}

McDade, Eric ^{[1
]}

Morris, John C. ^{[1
]}

Benzinger, Tammie L. S. ^{[1
]}

Bateman, Randall J. ^{[1
]}

Ances, Beau M. ^{[1
]}

机构：

[1] Washington Univ St Louis, St Louis, MO USA

[2] Univ Pittsburgh, Pittsburgh, PA USA

[3] Massachusetts Gen Hosp, Brigham & Womens Hosp, Boston, MA 02114 USA

[4] Indiana Univ, Bloomington, IN USA

[5] UCL Queen Sq Inst Neurol, Dementia Res Ctr, London, England

[6] German Ctr Neurodegenerat Dis, Tubingen, Germany

[7] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany

[8] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany

[9] German Ctr Neurodegenerat Dis, Munich, Germany

[10] Munich Cluster Syst Neurol SyNergy, Munich, Germany

[11] Univ Melbourne, Florey Inst, Parkville, Vic, Australia

[12] Nagaoka Sutoku Univ, Osaka City Univ, Sch Med, Abeno Ku, Osaka, Japan

[13] Columbia Univ Irving Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, GH Sergievsky Ctr, New York, NY USA

[14] Columbia Univ Irving Med Ctr, Dept Neurol, New York, NY USA

[15] Brown Univ, Butler Hosp, Providence, RI 02912 USA

[16] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA

[17] Neurosci Res Australia, Randwick, NSW, Australia

[18] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia

[19] Royal Prince Alfred Hosp, Dept Mol Imaging, Camperdown, NSW, Australia

[20] Univ Sydney, Sydney, NSW, Australia

[21] Mayo Clin, Rochester, MN USA

[22] Ludwig Maximilians Univ Munchen, Dept Neurol, Munich, Germany

[23] German Ctr Neurodegenerat Dis DZNE, Munich, Germany

[24] Univ Michigan, Ann Arbor, MI 48109 USA

[25] Banner Alzheimer Inst, Phoenix, AZ USA

[26] Univ Calif San Francisco, San Francisco, CA 94143 USA

[27] San Francisco VA Med Ctr, San Francisco, CA USA

来源：

ALZHEIMERS & DEMENTIA | 2023年 / 19卷 / 01期

基金：

美国国家卫生研究院; 英国医学研究理事会;

关键词：

Autosomal dominant Alzheimer's disease; biomarkers; machine learning; FLUID BIOMARKER; PET; YKL-40;

D O I：

10.1002/alz.12661

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

INTRODUCTION As the number of biomarkers used to study Alzheimer's disease (AD) continues to increase, it is important to understand the utility of any given biomarker, as well as what additional information a biomarker provides when compared to others. METHODS We used hierarchical clustering to group 19 cross-sectional biomarkers in autosomal dominant AD. Feature selection identified biomarkers that were the strongest predictors of mutation status and estimated years from symptom onset (EYO). Biomarkers identified included clinical assessments, neuroimaging, cerebrospinal fluid amyloid, and tau, and emerging biomarkers of neuronal integrity and inflammation. RESULTS Three primary clusters were identified: neurodegeneration, amyloid/tau, and emerging biomarkers. Feature selection identified amyloid and tau measures as the primary predictors of mutation status and EYO. Emerging biomarkers of neuronal integrity and inflammation were relatively weak predictors. DISCUSSION These results provide novel insight into our understanding of the relationships among biomarkers and the staging of biomarkers based on disease progression.

引用

页码：274 / 284

页数：11

共 50 条

[1] Plasma biomarker profiles in autosomal dominant Alzheimer's disease
Johansson, Charlotte
Thordardottir, Steinunn
Laffita-Mesa, Jose
Rodriguez-Vieitez, Elena
Zetterberg, Henrik
Blennow, Kaj
Graff, Caroline
BRAIN, 2023, 146 (03) : 1132 - 1140
[2] NEUROIMAGING IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE
Fleisher, Adam S.
NEUROBIOLOGY OF AGING, 2014, 35 : S7 - S7
[3] Preclinical CSF proteomic changes: a milestone in biomarker detection for autosomal dominant Alzheimer's disease
Ross, J. Alexander
Dodel, Richard
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
[4] Misfolded α-Synuclein in Autosomal Dominant Alzheimer's Disease
Fort-Aznar, Laura
Molina-Porcel, Laura
Ramos-Campoy, Oscar
Esteller, Diana
Naranjo, Laura
Llado, Albert
Balasa, Mircea
Ruiz-Garcia, Raquel
Antonell, Anna
Sanchez-Valle, Raquel
JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (03) : 1091 - 1096
[5] Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
Randall J Bateman
Paul S Aisen
Bart De Strooper
Nick C Fox
Cynthia A Lemere
John M Ringman
Stephen Salloway
Reisa A Sperling
Manfred Windisch
Chengjie Xiong
Alzheimer's Research & Therapy, 3
[6] Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
Bateman, Randall J.
Aisen, Paul S.
De Strooper, Bart
Fox, Nick C.
Lemere, Cynthia A.
Ringman, John M.
Salloway, Stephen
Sperling, Reisa A.
Windisch, Manfred
Xiong, Chengjie
ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (01)
[7] Associations of category fluency clustering performance with in vivo brain pathology in autosomal dominant Alzheimer's disease
Yucebas, Defne
Fox-Fuller, Joshua T.
Cabrera, Alex Badillo
Baena, Ana
McDowell, Celina Pluim
Aduen, Paula
Vila-Castelar, Clara
Bocanegra, Yamile
Tirado, Victoria
Sanchez, Justin S.
Cronin-Golomb, Alice
Lopera, Francisco
Quiroz, Yakeel T.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2024, 30 (01) : 77 - 83
[8] Alzheimer disease: Autosomal dominant forms
Guyant-Marechal, L.
Campion, D.
Hannequin, D.
REVUE NEUROLOGIQUE, 2009, 165 (03) : 223 - 231
[9] Discovery and validation of autosomal dominant Alzheimer’s disease mutations
Simon Hsu
Brian A. Gordon
Russ Hornbeck
Joanne B. Norton
Denise Levitch
Adia Louden
Ellen Ziegemeier
Robert Laforce
Jasmeer Chhatwal
Gregory S. Day
Eric McDade
John C. Morris
Anne M. Fagan
Tammie L. S. Benzinger
Alison M. Goate
Carlos Cruchaga
Randall J. Bateman
Celeste M. Karch
Alzheimer's Research & Therapy, 10
[10] Pattern of Biomarkers in autosomal-dominant Alzheimer's Disease
Numberger, Markus
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (07) : 343 - 343

← 1 2 3 4 5 →